|
|
|
Volumn 19, Issue 1, 2000, Pages 29-34
|
|
Mother-to-child HIV-1 transmission: state of the art and implications for public policy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
LAMIVUDINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS RNA;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
CESAREAN SECTION;
CLINICAL TRIAL;
DISEASE TRANSMISSION;
FEMALE;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
ISOLATION AND PURIFICATION;
MALE;
MONITORING;
NEWBORN;
POLICY;
PREGNANCY;
PREGNANCY COMPLICATION;
REGISTER;
REVIEW;
RISK FACTOR;
VIRUS LOAD;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADULT;
ANTI-HIV AGENTS;
CESAREAN SECTION;
CLINICAL TRIALS;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV-1;
HUMANS;
INFANT, NEWBORN;
LAMIVUDINE;
MALE;
MONITORING, PHYSIOLOGIC;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PUBLIC POLICY;
REGISTRIES;
REVERSE TRANSCRIPTASE INHIBITORS;
RISK FACTORS;
RNA, VIRAL;
VIRAL LOAD;
ZIDOVUDINE;
|
|
EID: 0034150330
PISSN: 07380658
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (26)
|
